MURTY PHARMACEUTICALS, INC.

Basic Information

MURTY PHARMACEUTICALS, INC.
518 CODELL DR
LEXINGTON, KY, 40509

Company Profile

n/a

Additional Details

Field Value
DUNS: 943117366
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Nasal Delivery of Ondansetron for Treatment of Alcoholism

    Amount: $119,672.00

    DESCRIPTION (provided by applicant): Alcohol abuse, dependence, and related societal effects exert a tremendous toll on world-wide and American health and economics. Given this devastating impact, the ...

    SBIR Phase I 2008 Department of Health and Human Services
  2. NOVEL THERAPY FOR MARIJUANA ADDICTION

    Amount: $99,884.00

    N/A

    SBIR Phase I 2006 Department of Health and Human Services
  3. ISOLATION OF POTENTIAL ANTI-CANCER DRUGS BY SUPERCRITICAL FLUID EXTRACTION

    Amount: $0.00

    N/A

    SBIR Phase I 2002 Department of Health and Human Services
  4. ISOLATION OF POTENTIAL ANTI-CANCER DRUGS BY SUPERCRITICAL FLUID EXTRACTION

    Amount: $749,879.00

    N/A

    SBIR Phase II 2002 Department of Health and Human Services
  5. TRANSDERMAL DELIVERY OF TETRAHYDROCANNABINOL

    Amount: $0.00

    N/A

    SBIR Phase I 2002 Department of Health and Human Services
  6. TRANSDERMAL DELIVERY OF TETRAHYDROCANNABINOL

    Amount: $363,010.00

    N/A

    SBIR Phase II 2002 Department of Health and Human Services
  7. DEVELOPMENT OF PLACEBO MARIJUANA CIGARETTES

    Amount: $0.00

    N/A

    SBIR Phase I 2002 Department of Health and Human Services
  8. DEVELOPMENT OF PLACEBO MARIJUANA CIGARETTES

    Amount: $363,624.00

    N/A

    SBIR Phase II 2002 Department of Health and Human Services
  9. N/A

    Amount: $99,691.00

    N/A

    SBIR Phase I 2001 Department of Health and Human Services
  10. N/A

    Amount: $0.00

    N/A

    SBIR Phase I 2001 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government